Adage Capital Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Adage Capital Partners’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,936,633	Closed	-$340M	–	968
2023 Q3	$340M	Sell	2,936,633 -57,973	-2%	-$6.23M	0.77%	18
2023 Q2	$308M	Buy	2,994,606 +435,694	+17%	+$46M	0.67%	21
2023 Q1	$279M	Buy	2,558,912 +1,015,212	+66%	+$112M	0.63%	20
2022 Q4	$176M	Buy	1,543,700 +537,457	+53%	+$44.6M	0.42%	37
2022 Q3	$62.3M	Buy	1,006,243 +888,743	+756%	+$62.1M	0.15%	155
2022 Q2	$9.37M	Sell	117,500 -262,500	-69%	-$24.9M	0.02%	689
2022 Q1	$40M	Buy	380,000 +230,000	+153%	+$22.4M	0.08%	274
2021 Q4	$16.2M	Sell	150,000 -1,755,000	-92%	-$191M	0.03%	553
2021 Q3	$209M	Sell	1,905,000 -345,000	-15%	-$35.8M	0.41%	49
2021 Q2	$211M	Buy	2,250,000 +650,000	+41%	+$59.8M	0.41%	45
2021 Q1	$147M	Sell	1,600,000 -850,000	-35%	-$71.7M	0.3%	70
2020 Q4	$179M	Sell	2,450,000 -1,240,772	-34%	-$92.2M	0.39%	46
2020 Q3	$287M	Buy	3,690,772 +434,823	+13%	+$29.9M	0.72%	17
2020 Q2	$181M	Buy	+3,255,949	New	+$139M	0.46%	39
2020 Q1	–	Sell	-1,000,000	Closed	-$36.2M	–	818
2019 Q4	$36.2M	Sell	1,000,000 -500,000	-33%	-$15.3M	0.09%	262
2019 Q3	$40.8M	Buy	1,500,000 +100,000	+7%	+$2.59M	0.1%	233
2019 Q2	$33.7M	Buy	1,400,000 +400,000	+40%	+$10.1M	0.08%	267
2019 Q1	$26.4M	Buy	1,000,000 +425,000	+74%	+$10.1M	0.07%	319
2018 Q4	$11.2M	Buy	+575,000	New	+$11.3M	0.03%	488
2014 Q2	–	Sell	-350,000	Closed	-$5.29M	–	766
2014 Q1	$5.29M	Buy	+350,000	New	+$3.95M	0.01%	583

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Adage Capital Partners's HZNP Position: Q4 2023 in Review

Adage Capital Partners sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 2,936,633 shares — an estimated $340M sold.

Adage Capital Partners first reported a position in HZNP in Q1 2014 and held it in 20 quarters. The position peaked at $340M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Adage Capital Partners reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Adage Capital Partners sold 2,936,633 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $340M.
Adage Capital Partners first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2014 and held it in 20 quarters.
Adage Capital Partners's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $340M in Q3 2023.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Adage Capital Partners's 13F filing for Q4 2023, filed 14 Feb 2024.